Lenalidomide in Combination With Bendamustine and Rituximab for Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma(CLL/SLL): a Phase I Study
Phase of Trial: Phase I
Latest Information Update: 30 Jan 2018
At a glance
- Drugs Lenalidomide (Primary) ; Bendamustine; Rituximab
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions
- 23 Jan 2018 Status changed from active, no longer recruiting to completed.
- 17 Dec 2016 Planned End Date changed from 1 Nov 2013 to 1 Dec 2018.
- 17 Dec 2016 Planned primary completion date changed from 1 Nov 2014 to 1 Dec 2017.